结核分枝杆菌生物膜研究进展
Advances on Research of Mycobacterium tuberculosis Biofilms
DOI: 10.12677/HJMCe.2018.63011, PDF,    国家自然科学基金支持
作者: 甘梦兰*, 王仁凤, 杨再昌:贵州大学药学院,贵州 贵阳
关键词: 结核分枝杆菌生物膜耐受性Mycobacterium tuberculosis Biofilms Tolerance
摘要: 生物膜是指被自我产生的细胞外聚合物包裹,并附着在细胞表面的微生物群落,但结核分枝杆菌生物膜的生理学和遗传学定义至今尚未被描述。抗菌药物耐受性通常与之形成的生物膜有关,结核分枝杆菌生物膜因其独特的生理状态,限制了抗结核药物的治疗效果,延长了结核病治疗的周期,严重危害人类健康。该文就结核分枝杆菌生物膜的形成机制、结构成分及相关功能、定量测定方法进行了综述,讨论了以结核分枝杆菌生物膜为靶点新型抗痨药物的研究思路,为缩短结核病治疗时间,提高结核病的治疗效果提供一个新方向。
Abstract: Biofilms refer to a microbial community that is surrounded by a self-generated extracellular po-lymer and attached to the cell surface, but the physiology and genetics definition of the M. tuber-culosis biofilm have not yet been described. Because of its unique physiological state, M. tuberculo-sis biofilms limit the therapeutic effect of anti-tuberculosis drugs, prolong the cycle of tuberculosis treatment, and seriously endanger human health. This article reviewed the formation mechanism, structural composition and related functions and quantitative methods of M. tuberculosis biofilms, and discussed the research ideas of using M. tuberculosis biofilms as novel anti-tuberculosis drugs to shorten the treatment of tuberculosis and provide a new direction for improving the therapeutic effect of tuberculosis.
文章引用:甘梦兰, 王仁凤, 杨再昌. 结核分枝杆菌生物膜研究进展[J]. 药物化学, 2018, 6(3): 78-84. https://doi.org/10.12677/HJMCe.2018.63011

参考文献

[1] Coenye, T. and Nelis, H.J. (2010) In Vitro and in Vivo Model Systems to Study Microbial Biofilm Formation. Journal of Microbiological Methods, 83, 89-105. [Google Scholar] [CrossRef] [PubMed]
[2] Hall-Stoodley, L. and Lap-pin-Scott, H. (1998) Biofilm Formation by the Rapidly Growing Mycobacterial Species Mycobacterium fortuitum. FEMS Microbiology Letters, 168, 77-84. [Google Scholar] [CrossRef] [PubMed]
[3] Ojha, A.K., Baughn, A.D., Sambandan, D., et al. (2008) Growth of Mycobacterium tuberculosis Biofilms Containing Free Mycolic Acids and Harbouring Drug-Tolerant Bacteria. Molecular Microbiology, 69, 164-174. [Google Scholar] [CrossRef] [PubMed]
[4] Jahid, I.K. and Ha, S.-D. (2012) A Review of Microbial Bio-films of Produce: Future Challenge to Food Safety. Food Science and Biotechnology, 21, 299-316. [Google Scholar] [CrossRef
[5] Kumara, A., Alama, A., Rani, M., et al. (2017) Biofilms: Survival and Defense Strategy for Pathogens. Journal of Medical Microbiology, 307, 481-489. [Google Scholar] [CrossRef] [PubMed]
[6] Islam, M.S., Richards, J.P. and Ojha, A.K. (2012) Targeting Drug Tolerance in Mycobacteria: A Perspective from Mycobacterial Biofilms. Expert Review of Anti-Infective Therapy, 10, 1055-1066. [Google Scholar] [CrossRef] [PubMed]
[7] Ukuku, D.O. and Fett, W.F. (2002) Relationship of Cell Surface Charge and Hydrophobicity to Strength of Attachment of Bacteria to Cantaloupe Rind. Journal of Food Protection, 65, 1093-1099. [Google Scholar] [CrossRef
[8] Ogasawara, H., Yamamoto, K. and Ishihama, A. (2011) Role of the Biofilm Master Regulator CsgD in Cross-Regulation between Biofilm Formation and Flagellar Synthesis. Journal of Bacteriology, 193, 2587-2597. [Google Scholar] [CrossRef
[9] Costerton, J.W., Stewart, P.S. and Greenberg, E.P. (1999) Bacterial Biofilms: A Common Cause of Persistent Infections. Science, 284, 1318-1321. [Google Scholar] [CrossRef] [PubMed]
[10] Mckenney, D., Hubner, J., Muller, E., et al. (1998) Theica Locus of Staphylococcus epidermidis Encodes Production of the Capsular Polysaccharide/Adhesin. Infection and Immunity, 66, 4711-4720.
[11] Stewart, P.S., McFeters, G.A. and Huang, C.T. (2000) Biofilm Control by Antimicrobial Agents. In: Bryers, J.D., (Ed.), Biofilms, 2nd edition, John Wiley & Sons, Inc., New York, 373-405.
[12] Stoodley, P., DeBeer, D. and Lewandowski, Z. (1994) Liquid flow in Biofilm Systems. Applied and Environmental Microbiology, 60, 2711-2716.
[13] Vasudevan, R. (2014) Biofilms: Microbial Cities of Scientific Significance. Journal of Microbiology and Experimentation, 1, 1-16. [Google Scholar] [CrossRef
[14] Davies, D.G., Parsek, M.R., Pearson, J.P., et al. (1998) The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm. Science, 280, 295-298. [Google Scholar] [CrossRef] [PubMed]
[15] Sutherland, I.W. (1999) Polysaccharases for Microbial Exopolysaccharides. Carbohydrate Polymers, 38, 319-328. [Google Scholar] [CrossRef
[16] Trivedi, A., Mavi, P.S., Bhatt, D., et al. (2016) Thiol Reductive Stress Induces Cellulose-Anchored Biofilm Formation in Mycobacterium tuberculosis. Nature Communications, 7, Ar-ticle No. 11392. [Google Scholar] [CrossRef] [PubMed]
[17] Sun, D., Accavitti, M.A. and Bryers, J.D. (2005) Inhibition of Biofilm Formation by Monoclonal Antibodies against Staphylococcus epidermidis RP62A Accumulation-Associated Protein. Clinical and Diagnostic Laboratory Immunology, 12, 93-100.
[18] Stepanovic, S., Vukovic, D., Hola, V., et al. (2007) Quantification of Biofilm in Microtiter Plates: Overview of Testing Conditions and Practical Recommendations for Assessment of Biofilm Production by Staphylococci. APMIS, 115, 891-899. [Google Scholar] [CrossRef] [PubMed]
[19] Peeters, E., Nelis, H.J. and Coenye, T. (2008) Comparison of Multiple Methods for Quantification of Microbial Biofilms Grown in Microtiter Plates. Journal of Microbiological Methods, 72, 157-165. [Google Scholar] [CrossRef] [PubMed]
[20] Christensen, G.D., Simpson, W., Younger, J., et al. (1985) Adherence of Coagulase-Negative Staphylococci to Plastic Tissue Culture Plates: A Quantitative Model for the Adherence of Staphylococci to Medical Devices. Journal of Clinical Microbiology, 22, 996-1006.
[21] Pantanella, F., Valenti, P., Natalizi, T., et al. (2013) Analytical Techniques to Study Microbial Biofilm on Abiotic Surfaces: Pros and Cons of the Main Techniques Currently in Use. Ann Ig, 25, 31-42.
[22] Mothiba, M.T., Anderson, R., Fourie, B., et al. (2015) Ef-fects of Clofazimine on Planktonic and Biofilm Growth of Mycobacterium tuberculosis and Mycobacterium smegmatis. Journal of Global Antimicrobial Resistance, 3, 13-18. [Google Scholar] [CrossRef] [PubMed]
[23] Gabrielson, J., Hart, M., Jarelöv, A., et al. (2002) Evaluation of Redox Indicators and the Use of Digital Scanners and Spectrophotometer for Quantification of Microbial Growth in Microplates. Journal of Microbiological Methods, 50, 63-73. [Google Scholar] [CrossRef
[24] Ginouves, M., Carme, B., Couppie, P., et al. (2014) Comparison of Tetrazolium Salt Assays for Evaluation of Drug Activity against Leishmania spp. Journal of Clinical Microbiology, 52, 2131-2138. [Google Scholar] [CrossRef
[25] Xu, Z., Liang, Y., Lin, S., et al. (2016) Crystal Violet and XTT Assays on Staphylococcus aureus Biofilm Quantification. Current Microbiology, 73, 1-9. [Google Scholar] [CrossRef] [PubMed]
[26] Adam, B., Baillie, G.S. and Douglas, L.J. (2002) Mixed Species Bio-films of Candida albicans and Staphylococcus epidermidis. Journal of Medical Microbiology, 51, 344-349. [Google Scholar] [CrossRef] [PubMed]
[27] Honraet, K., Goetghebeur, E. and Nelis, H.J. (2005) Comparison of Three Assays for the Quantification of Candida Biomass in Suspension and CDC Reactor Grown Biofilms. Journal of Microbiological Methods, 63, 287-295. [Google Scholar] [CrossRef] [PubMed]
[28] Pettit, R.K., Weber, C.A., Kean, M.J., et al. (2005) Microplatealamar Blue Assay for Staphylococcus epidermidis Biofilm Susceptibility Testing. Antimicrobial Agents and Chemotherapy, 49, 2612-2617. [Google Scholar] [CrossRef
[29] Mariscal, A., Lopez-Gigosos, R.M., Carnero-Varo, M., et al. (2009) Fluorescent Assay Based on Resazurin for Detection of Activity of Disinfectants against Bacterial Biofilm. Ap-plied Microbiology and Biotechnology, 82, 773. [Google Scholar] [CrossRef] [PubMed]
[30] Sandberg, M.E., Schellmann, D., Brunhofer, G., et al. (2009) Pros and Cons of Using Resazurin Staining for Quantification of Viable Staphylococcus aureus Biofilms in a Screening Assay. Journal of Microbiological Methods, 78, 104-106. [Google Scholar] [CrossRef] [PubMed]
[31] O’Brien, J., Wilson, I., Orton, T., et al. (2000) Investigation of the Alamar Blue (Resazurin) Fluorescent Dye for the Assessment of Mammalian Cytotoxicity. European Journal of Biochemistry, 267, 5421-5426. [Google Scholar] [CrossRef] [PubMed]
[32] Skogman, M.E., Vuorela, P.M. and Fallarero, A. (2012) Com-bining Biofilm Matrix Measurements with Biomass and Viability Assays in Susceptibility Assessments of Antimicro-bials against Staphylococcus aureus Biofilms. The Journal of Antibiotics, 65, 453-459. [Google Scholar] [CrossRef] [PubMed]
[33] Banin, E., Vasil, M.L. and Greenberg, E.P. (2005) Iron and Pseudomonas ae-ruginosa Biofilm Formation. Proceedings of the National Academy of Sciences of the United States, 102, 11076-11081. [Google Scholar] [CrossRef] [PubMed]
[34] Pang, J.M., Layre, E., Sweet, L., et al. (2012) Thepolyketide Pks1 Con-tributes to Biofilm Formation in Mycobacterium tuberculosis. Journal of Bacteriology, 194, 715-721. [Google Scholar] [CrossRef
[35] Renner, L.D. and Weibel, D.B. (2011) Physicochemical Regulation of Biofilm Formation. MRS Bulletin, 36, 347-355. [Google Scholar] [CrossRef] [PubMed]
[36] Cegelski, L., Pinkner, J.S., Hammer, N.D., et al. (2009) Small-Molecule In-hibitors Target Escherichia coli Amyloid Biogenesis and Biofilm Formation. Nature Chemical Biology, 5, 913-919. [Google Scholar] [CrossRef] [PubMed]
[37] Ojha, A.K., Anand, M., Bhatt, A., et al. (2005) GroEL1: A Dedicated Chaperone Involved in Mycolic Acid Biosynthesis during Biofilm Formation in Mycobacteria. Cell, 123, 861-873. [Google Scholar] [CrossRef] [PubMed]
[38] Vilchèze, C., Wang, F., Arai, M., et al. (2006) Transfer of a Point Mu-tation in Mycobacterium tuberculosis inhA Resolves the Target of Isoniazid. Nature Medicine, 12, 1027-1029. [Google Scholar] [CrossRef] [PubMed]
[39] Xavier, J.B., Picioreanu, C., Rani, S.A., et al. (2005) Biofilm-Control Strategies Based on Enzymic Disruption of the Extracellular Polymeric Substance Matrix—A Modelling Study. Microbiology, 151, 3817-3832. [Google Scholar] [CrossRef] [PubMed]
[40] 林丽华, 余加林, 林雅茵, 等. 大蒜素对铜绿假单细胞生物膜早期粘附及胞外多糖的影响[J]. 中国微生态学杂志, 2009, 21(1): 9-12.
[41] 段高飞, 韩峰, 李京宝, 等. 细菌生物膜相关感染的防治方法研究进展[J]. 中国海洋大学学报, 2010, 40(5): 107-111.